EcoDrugPlus

Integrin Subunit Beta 1

Ensembl ID : ENSAMXG00000019081
Gene Symbol: ITGB1
3 Cross references
211 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSAMXG00000010900
Gene Symbol: ITGB5
3 Cross references
211 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSAMXG00000039846
Gene Symbol: ITGB6
1 Cross references
204 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSAMXG00000004704
Gene Symbol: ITGB8
3 Cross references
207 Possible Orthologues:

Integrin, Alpha V

Ensembl ID : ENSAMXG00000000110
Gene Symbol: ITGAV
1 Cross references
238 Possible Orthologues:

Integrin, Beta 1b.1

Ensembl ID : ENSAMXG00000012259
Gene Symbol: ITGB1B.1
2 Cross references
216 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSAMXG00000039490
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Inward Rectifier Potassium Channel 2-Like

Ensembl ID : ENSAMXG00000026032
Gene Symbol: LOC103029129
3 Cross references
202 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSAMXG00000015280
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSAMXG00000007438
Gene Symbol: IDH2
3 Cross references
250 Possible Orthologues:

Isotocin Receptor

Ensembl ID : ENSAMXG00000030671
Gene Symbol: LOC103033855
3 Cross references
193 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSAMXG00000011366
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).